Hemophagocytic Lymphohistiocytosis in Adults

Hematology/Oncology Clinics of North America

Volumn 29, Issue 5, 2015, Pages 915-925

  Campo, Meghan ^b   Berliner, Nancy ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Acquired hemophagocytic lymphohistiocytosis; Adults; Diagnosis; Hemophagocytic lymphohistiocytosis; Treatment

Indexed keywords

CYCLOSPORIN; DEXAMETHASONE; ETOPOSIDE; FERRITIN; HYDROCORTISONE; METHOTREXATE; RITUXIMAB; SOLUBLE INTERLEUKIN 2 RECEPTOR;

BLOOD CLOTTING DISORDER; CELL FUNCTION; CLINICAL FEATURE; CYTOPENIA; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS INFECTION; ERYTHROPHAGOCYTOSIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOPHAGOCYTIC SYNDROME; HUMAN; HYPERTRIGLYCERIDEMIA; INFECTION; LABORATORY TEST; MACROPHAGE ACTIVATION SYNDROME; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; MULTIPLE ORGAN FAILURE; NATURAL KILLER CELL; NEUROLOGIC DISEASE; PATIENT CARE; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; REVIEW; SKIN MANIFESTATION; ADULT; AGE; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MULTIMODALITY CANCER THERAPY; TREATMENT OUTCOME;

ADULT; AGE FACTORS; COMBINED MODALITY THERAPY; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; PROGNOSIS; RECURRENCE; TREATMENT OUTCOME;

EID: 84942365818     PISSN: 08898588     EISSN: 15581977     Source Type: Journal    
DOI: 10.1016/j.hoc.2015.06.009     Document Type: Review

References (32)

1. Ramos-Casals M., Brito-Zeron P., Lopez-Guillermo A., et al. Adult haemophagocytic syndrome. Lancet 2014, 383:1503-1516.
2. Riviere S., Galicier L., Coppo P., et al. Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients. Am J Med 2014, 127:1118-1125.
3. Zhang K., Jordan M.B., Marsh R.A., et al. Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. Blood 2011, 118:5794-5798.
4. Tseng Y.T., Sheng W.H., Lin B.H., et al. Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults. J Microbiol Immunol Infect 2011, 44:191-197.
5. Parikh S.A., Kapoor P., Letendre L., et al. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clin Proc 2014, 89:484-492.
6. Fukaya S., Yasuda S., Hashimoto T., et al. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology 2008, 47:1686-1691.
7. Jordan M.B., Allen C.E., Weitzman S., et al. How I treat hemophagocytic lymphohistiocytosis. Blood 2011, 118:4041-4052.
8. Haddad E., Sulis M.L., Jabado N., et al. Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood 1997, 89:794-800.
9. Henter J.I., Nennesmo I. Neuropathologic findings and neurologic symptoms in twenty-three children with hemophagocytic lymphohistiocytosis. J Pediatr 1997, 130:358-365.
10. Clementi R., Emmi L., Maccario R., et al. Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Blood 2002, 100:2266-2267.
11. Akima M., Sumi S.M. Neuropathology of familial erythrophagocytic lymphohistiocytosis: six cases and review of the literature. Hum Pathol 1984, 15:161-168.
12. Morrell D.S., Pepping M.A., Scott J.P., et al. Cutaneous manifestations of hemophagocytic lymphohistiocytosis. Arch Dermatol 2002, 138:1208-1212.
13. Fardet L., Galicier L., Vignon-Pennamen M.D., et al. Frequency, clinical features and prognosis of cutaneous manifestations in adult patients with reactive haemophagocytic syndrome. Br J Dermatol 2010, 162:547-553.
14. Allen C.E., Yu X., Kozinetz C.A., et al. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2008, 50:1227-1235.
15. Schram A.M., Campigotto F., Mullally A., et al. Marked hyperferritinemia does not predict for HLH in the adult population. Blood 2015, 125:1548-1552.
16. Ost A., Nilsson-Ardnor S., Henter J.I. Autopsy findings in 27 children with haemophagocytic lymphohistiocytosis. Histopathology 1998, 32:310-316.
17. Weitzman S. Approach to hemophagocytic syndromes. Hematology Am Soc Hematol Educ Program 2011, 2011:178-183.
18. Chung H.J., Park C.J., Lim J.H., et al. Establishment of a reference interval for natural killer cell activity through flow cytometry and its clinical application in the diagnosis of hemophagocytic lymphohistiocytosis. Int J Lab Hematol 2010, 32:239-247.
19. Filipovich A.H. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology Am Soc Hematol Educ Program 2009, 127-131.
20. Tsuji T., Hirano T., Yamasaki H., et al. A high sIL-2R/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome. Ann Hematol 2014, 93:821-826.
21. Kaito K., Kobayashi M., Katayama T., et al. Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases. Eur J Haematol 1997, 59:247-253.
22. Otrock Z.K., Eby C.S. Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis. Am J Hematol 2015, 90:220-224.
23. Arca M., Fardet L., Galicier L., et al. Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide. Br J Haematol 2015, 168:63-68.
24. Li J., Wang Q., Zheng W., et al. Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients. Medicine 2014, 93:100-105.
25. Imashuku S. Treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis (EBV-HLH); update 2010. J Pediatr Hematol Oncol 2011, 33:35-39.
26. Trottestam H., Horne A., Arico M., et al. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood 2011, 118:4577-4584.
27. Henter J.I., Horne A., Arico M., et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007, 48:124-131.
28. Marsh R.A., Allen C.E., McClain K.L., et al. Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab. Pediatr Blood Cancer 2013, 60:101-109.
29. Chellapandian D., Das R., Zelley K., et al. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens. Br J Haematol 2013, 162:376-382.
30. Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol 2002, 14:548-552.
31. Durand M., Troyanov Y., Laflamme P., et al. Macrophage activation syndrome treated with anakinra. J Rheumatol 2010, 37:879-880.
32. Sakai R., Nagasawa H., Nishi E., et al. Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review. Clin Rheumatol 2012, 31:569-574.